Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Xiao, Wenhua ^a   Dong, Weiwei ^a   Zhang, Caihong ^b   Saren, Gaowa ^c   Geng, Paili ^b   Zhao, Huixia ^a   Li, Quiwen ^a   Zhu, Jianhua ^a   Li, Guanghui ^a   Zhang, Shufang ^a   Ye, Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b QINGHAI UNIVERSITY   (China)

^c INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

Exosomes; HepG2; HSP70; MICA; MICB; NK cell

Indexed keywords

ENTINOSTAT; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HLA A ANTIGEN; HLA B ANTIGEN; BENZAMIDE DERIVATIVE; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; PYRIDINE DERIVATIVE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CARCINOMA CELL; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY ASSAY; DRUG EFFECT; EPIGENETICS; EXOSOME; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; IMMUNOSTIMULATION; LIVER CELL CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; WESTERN BLOTTING; CELL PROLIFERATION; CELL STRAIN HEPG2; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; LIVER TUMOR; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; ULTRASTRUCTURE;

BENZAMIDES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; EPIGENESIS, GENETIC; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HSP70 HEAT-SHOCK PROTEINS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LIVER NEOPLASMS; PYRIDINES;

EID: 84890616179     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-61     Document Type: Article

References (29)

1. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, Nohroudi K, Kufer TA, Engert A, Pogge von Strandmann E, PLoS One 2008 3 3377 10.1371/journal.pone.0003377 18852879
2. Secretion of alphaB-Crystallin via exosomes: new clues to the function of human retinal pigment epithelium. Bhat SP, Gangalum RK, Commun Integr Biol 2011 4 739 741 22446542
3. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D, et al. J Clin Invest 2010 120 457 471 20093776
4. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113 (Pubitemid 47214727)
5. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S, J Immunol 2001 166 7309 7318 11390481 (Pubitemid 32525606)
6. Cells release prions in association with exosomes. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G, Proc Natl Acad Sci USA 2004 101 9683 9688 10.1073/pnas.0308413101 15210972 (Pubitemid 38869296)
7. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes. Lee HD, Koo BH, Kim YH, Jeon OH, Kim DS, FASEB J 2012 26 3084 3095 10.1096/fj.11-201681 22505472
8. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R, Cancer Immunol Immunother 2011 60 639 648 10.1007/s00262-011-0979- 5 21293856
9. Exosomes in tumor microenvironment influence cancer progression and metastasis. Kahlert C, Kalluri R, J Mol Med 2013 91 431 437 10.1007/s00109-013- 1020-6 23519402
10. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. Yang C, Kim SH, Bianco NR, Robbins PD, PLoS One 2011 6 22517 10.1371/journal.pone.0022517 21829629
11. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy. Quah B, O'Neill HC, Cancer Biother Radiopharm 2000 15 185 194 10.1089/cbr.2000.15.185 10803324 (Pubitemid 30305970)
12. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang YH, Yang XH, Liu YP, Dig Liver Dis 2009 41 875 880 10.1016/j.dld.2009.04.006 19473897
13. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P, Cancer Lett 2009 278 73 81 10.1016/j.canlet.2008.12.028 19188015
14. Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. Vissers MC, Jester SA, Fantone JC, J Immunol Methods 1988 110 203 207 10.1016/0022-1759(88)90104-4 2837516
15. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. Lancaster GI, Febbraio MA, J Biol Chem 2005 280 23349 23355 10.1074/jbc.M502017200 15826944 (Pubitemid 40853248)
16. Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Nakano M, Mann DL, Knowlton AA, Circulation 1997 95 1523 1531 10.1161/01.CIR.95.6.1523 9118521 (Pubitemid 27142811)
17. Development of an in vitro model for vascular injury with human endothelial cells. Schleger C, Platz SJ, Deschl U, Altex 2004 21 Suppl 3 12 19 15057404 (Pubitemid 38979453)
18. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ, J Cell Sci 2000 113 3365 3374 10984428
19. The biogenesis and functions of exosomes. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G, Traffic 2002 3 321 330 10.1034/j.1600-0854.2002.30502.x 11967126 (Pubitemid 34461042)
20. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z, Cancer Res 2007 67 7458 7466 10.1158/0008-5472.CAN-06-3456 17671216 (Pubitemid 47214451)
21. Heat shock proteins, autoimmunity, and cancer treatment. Calderwood SK, Stevenson MA, Murshid A, Autoimmun Dis 2012 2012 486069
22. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. Setiadi AF, Omilusik K, David MD, Seipp RP, Hartikainen J, Gopaul R, Choi KB, Jefferies WA, Cancer Res 2008 68 9601 9607 10.1158/0008-5472.CAN-07-5270 19047136
23. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, Vidal M, Amson R, Telerman A, Cell Death Differ 2008 15 1723 1733 10.1038/cdd.2008.104 18617898
24. The regulation of exosome secretion: a novel function of the p53 protein. Yu X, Harris SL, Levine AJ, Cancer Res 2006 66 4795 4801 10.1158/0008-5472.CAN- 05-4579 16651434
25. Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro. Deubzer HE, Ehemann V, Kulozik AE, Westermann F, Savelyeva L, Kopp-Schneider A, Riester D, Schwab M, Witt O, Cancer Lett 2008 264 21 28 10.1016/j.canlet.2008.01.002 18262346
26. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Peart MJ, Smyth GK, van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW, Proc Natl Acad Sci U S A 2005 102 3697 3702 10.1073/pnas.0500369102 15738394 (Pubitemid 40354674)
27. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, Altucci L, Nervi C, Minucci S, Pelicci PG, Nat Med 2005 11 71 76 10.1038/nm1160 15619634 (Pubitemid 40215840)
28. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. Khan AN, Gregorie CJ, Tomasi TB, Cancer Immunol Immunother 2008 57 647 654 10.1007/s00262-007-0402-4 18046553
29. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Thielens A, Vivier E, Romagne F, Curr Opin Immunol 2012 24 239 245 10.1016/j.coi.2012.01.001 22264929